MEN1 and primary hyperparathyroidism: Parathyroid tumors, resulting in primary hyperparathyroidism (PHPT), affect up to 95% of MEN1 patients and represent the first manifestation of the syndrome, with more than 85% of cases between ages 20 and 25 years (1, 39, 41, 42).